COPA SYNDROME

Clinical trials for COPA SYNDROME explained in plain language.

Never miss a new study

Get alerted when new COPA SYNDROME trials appear

Sign up with your email to follow new studies for COPA SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug hope for rare childhood immune disorders

Disease control Recruiting now

This early-stage trial tests a new medicine called IMSB301 in people with rare diseases where the immune system attacks the body. The study includes up to 6 participants aged 12 and older. The main goal is to check if the drug is safe and how it behaves in the body.

Matched conditions: COPA SYNDROME

Phase: PHASE1 • Sponsor: ImmuneSensor Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC

COPA SYNDROME

Get alerted when new COPA SYNDROME trials appear

New drug hope for rare childhood immune disorders